Abstract
Objective: We found a novel marine drug, SZ–685C, that was isolated from the secondary metabolites of a mangrove endophytic fungus (No. 1403) collected from the South China Sea, which has been reported to inhibit the proliferation of certain tumor cells. However, its anticancer mechanism remains unknown. The aims of this study were to observe the effectiveness of SZ–685C on pituitary adenoma cells and determine the underlying mechanisms of action.
Methods: A rat prolactinoma cell line, MMQ, was used in this study. A dose escalation of SZ–685C was performed on this cell line, and cell viability was assessed using an MTT assay. Hoechst 33342, Annexin V–FITC/PI, TUNEL staining and flow cytometry were used to evaluate the extent of apoptosis at each concentration of SZ–685C. The effect of SZ–685C on prolactin expression was also evaluated using RT–PCR and immunoblotting. Quantitative RT–PCR was used to detect the expression of miR–200c in SZ–685C–stimulated MMQ cells and pituitary adenoma tissues. This miRNA was then overexpressed in MMQ cells via transfection of a miR–200c mimic to identify the mechanism underling the anti–tumor effect of SZ–685C.
Results: SZ–685C inhibited MMQ cell growth in a dose–dependent manner but showed little toxicity toward rat pituitary cells (RPCs). The IC50s of SZ–685C in MMQ cells and RPCs were 13.2 ± 1.3 mM and 49.1 ± 11.5 mM, respectively, which was statistically significant. Increasing numbers of apoptotic cells were observed in response to escalating concentrations of SZ–685C, and the expression level of prolactin (PRL) was inhibited. Nevertheless, the level of PRL mRNA was unchanged. Additionally, miR–200c was upregulated in MMQ cells compared with RPCs, and downregulation of miR– 200c was observed in SZ–685C–treated MMQ cells. Furthermore, the overexpression of miR–200c weakened the effect of SZ–685C–induced apoptosis of MMQ cells.
Conclusions: Our results suggest that SZ–685C induces MMQ cell apoptosis in a miR–200c–dependent manner. Therefore, SZ–685C might be a useful alternative treatment for pituitary adenoma.
Keywords: Pituitary adenoma, marine drug, SZ–685C, apoptosis, microRNA, miR–200c, prolactinoma, MMQ cell, mangrove endophytic fungus, treatment
Current Medicinal Chemistry
Title:A Novel Marine Drug, SZ–685C, Induces Apoptosis of MMQ Pituitary Tumor Cells by Downregulating miR–200c
Volume: 20 Issue: 16
Author(s): C.–H. Chen, W.–W. Xiao, X.–B. Jiang, J.–W. Wang, Z.–G. Mao, N. Lei, X. Fan, B.–B. Song, C.–X. Liao, H.–J. Wang, Z.–G. She and Y.–H. Zhu
Affiliation:
Keywords: Pituitary adenoma, marine drug, SZ–685C, apoptosis, microRNA, miR–200c, prolactinoma, MMQ cell, mangrove endophytic fungus, treatment
Abstract: Objective: We found a novel marine drug, SZ–685C, that was isolated from the secondary metabolites of a mangrove endophytic fungus (No. 1403) collected from the South China Sea, which has been reported to inhibit the proliferation of certain tumor cells. However, its anticancer mechanism remains unknown. The aims of this study were to observe the effectiveness of SZ–685C on pituitary adenoma cells and determine the underlying mechanisms of action.
Methods: A rat prolactinoma cell line, MMQ, was used in this study. A dose escalation of SZ–685C was performed on this cell line, and cell viability was assessed using an MTT assay. Hoechst 33342, Annexin V–FITC/PI, TUNEL staining and flow cytometry were used to evaluate the extent of apoptosis at each concentration of SZ–685C. The effect of SZ–685C on prolactin expression was also evaluated using RT–PCR and immunoblotting. Quantitative RT–PCR was used to detect the expression of miR–200c in SZ–685C–stimulated MMQ cells and pituitary adenoma tissues. This miRNA was then overexpressed in MMQ cells via transfection of a miR–200c mimic to identify the mechanism underling the anti–tumor effect of SZ–685C.
Results: SZ–685C inhibited MMQ cell growth in a dose–dependent manner but showed little toxicity toward rat pituitary cells (RPCs). The IC50s of SZ–685C in MMQ cells and RPCs were 13.2 ± 1.3 mM and 49.1 ± 11.5 mM, respectively, which was statistically significant. Increasing numbers of apoptotic cells were observed in response to escalating concentrations of SZ–685C, and the expression level of prolactin (PRL) was inhibited. Nevertheless, the level of PRL mRNA was unchanged. Additionally, miR–200c was upregulated in MMQ cells compared with RPCs, and downregulation of miR– 200c was observed in SZ–685C–treated MMQ cells. Furthermore, the overexpression of miR–200c weakened the effect of SZ–685C–induced apoptosis of MMQ cells.
Conclusions: Our results suggest that SZ–685C induces MMQ cell apoptosis in a miR–200c–dependent manner. Therefore, SZ–685C might be a useful alternative treatment for pituitary adenoma.
Export Options
About this article
Cite this article as:
Chen C.–H., Xiao W.–W., Jiang X.–B., Wang J.–W., Mao Z.–G., Lei N., Fan X., Song B.–B., Liao C.–X., Wang H.–J., She Z.–G. and Zhu Y.–H., A Novel Marine Drug, SZ–685C, Induces Apoptosis of MMQ Pituitary Tumor Cells by Downregulating miR–200c, Current Medicinal Chemistry 2013; 20 (16) . https://dx.doi.org/10.2174/0929867311320160007
DOI https://dx.doi.org/10.2174/0929867311320160007 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the Treatment of Chronic Inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Evaluation of the in vitro Chemosensitivity and Correlation with Clinical Outcomes in Lung Cancer using the ATP-TCA
Anti-Cancer Agents in Medicinal Chemistry Characteristic Alterations of Nuclear Structure and Chromatin Organisation of Cancer Cells Addressed by Proteome Analysis**
Current Proteomics Anti-angiogenic Agents: A Review on Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Inhibitors
Current Medicinal Chemistry Pharmacological Targets for the Inhibition of Neurogenic Inflammation
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Recent Developments in the Field of Tumor-Inhibiting Metal Complexes
Current Pharmaceutical Design Anti-Invasive and Anti-Metastasis Strategies: New Roads, New Tools and New Hopes
Current Cancer Drug Targets Role of Biotransformation in Conceptal Toxicity of Drugs and Other Chemicals
Current Pharmaceutical Design Gene Therapy Using IL-12 Family Members in Infection, Auto-Immunity, and Cancer
Current Gene Therapy Molecular Mechanisms Regulating Matrix Metalloproteinases
Current Topics in Medicinal Chemistry Interactions of the Aryl Hydrocarbon Receptor with Inflammatory Mediators:Beyond CYP1A Regulation
Current Drug Metabolism The Endothelin Axis: A Novel Target for Pharmacotherapy of Female Malignancies
Current Vascular Pharmacology TGR5 as a Therapeutic Target for Treating Obesity
Current Topics in Medicinal Chemistry Strategies for Design of Non Peptide CCK1R Agonist/Antagonist Ligands
Current Topics in Medicinal Chemistry Spinal Microvascular Expression of PV-1 is Associated with Inflammation, Perivascular Astrocyte Loss, and Diminished EC Glucose Transport Potential in Acute SCI
Current Neurovascular Research ATP Citrate Lyase Inhibitors as Novel Cancer Therapeutic Agents
Recent Patents on Anti-Cancer Drug Discovery The Ubiquitin-Proteasome System (UPS) and the Mechanism of Action of Bortezomib
Current Pharmaceutical Design Design of New Oxazaphosphorine Anticancer Drugs
Current Pharmaceutical Design Botulinum Toxin: Pharmacology and Clinical Developments: A Literature Review
Medicinal Chemistry Tumor Angiogenesis and VEGFR-2: Mechanism, Pathways and Current Biological Therapeutic Interventions
Current Drug Metabolism TNFα Modulation of Visceral and Spinal Sensory Processing
Current Pharmaceutical Design